T1	Participants 47 107	patients with acute ischaemic stroke and atrial fibrillation
T2	Participants 212 272	Patients with acute ischaemic stroke and atrial fibrillation
T3	Participants 589 672	low-molecular-weight heparin (LMWH, dalteparin 100 IU/kg subcutaneously twice a day
T4	Participants 674 702	or aspirin (160 mg every day
T5	Participants 725 789	449 patients with acute ischaemic stroke and atrial fibrillation
